Palo Alto Investors LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,205,215
-43.6%
278,985
-13.9%
0.11%
-34.1%
Q2 2023$2,135,641
-34.8%
324,073
-32.9%
0.17%
-36.4%
Q1 2023$3,277,513
-59.2%
482,697
-55.6%
0.27%
-60.3%
Q4 2022$8,037,416
-62.4%
1,087,607
-49.8%
0.68%
-59.5%
Q3 2022$21,402,000
-21.2%
2,166,156
-13.0%
1.69%
-28.5%
Q2 2022$27,154,000
-3.6%
2,491,2000.0%2.37%
+8.7%
Q1 2022$28,175,000
-36.6%
2,491,200
-12.1%
2.18%
-23.4%
Q4 2021$44,469,000
-31.6%
2,834,244
-25.3%
2.84%
-27.6%
Q3 2021$64,992,000
-20.3%
3,791,8050.0%3.92%
-12.7%
Q2 2021$81,562,000
+43.2%
3,791,8050.0%4.50%
+38.5%
Q1 2021$56,953,000
+2.5%
3,791,805
-10.4%
3.24%
+11.4%
Q4 2020$55,589,000
+38.0%
4,230,548
+1.4%
2.91%
+31.8%
Q3 2020$40,285,000
-14.5%
4,170,281
+1.3%
2.21%
-21.8%
Q2 2020$47,093,000
+9.9%
4,116,548
-0.4%
2.83%
-21.2%
Q1 2020$42,837,000
-42.3%
4,134,846
-8.6%
3.59%
-12.3%
Q4 2019$74,263,000
+22.1%
4,525,476
-1.2%
4.09%
+0.9%
Q3 2019$60,838,000
-14.6%
4,581,176
-9.4%
4.05%
+17.0%
Q2 2019$71,226,000
-23.4%
5,055,0500.0%3.46%
-10.7%
Q1 2019$93,013,000
-14.3%
5,055,050
+21.6%
3.88%
-32.9%
Q4 2018$108,588,000
+13.9%
4,155,6700.0%5.78%
+50.0%
Q3 2018$95,373,000
+20.5%
4,155,6700.0%3.86%
+21.8%
Q2 2018$79,166,000
+13.1%
4,155,6700.0%3.16%
+5.7%
Q1 2018$70,023,000
+10.9%
4,155,6700.0%2.99%
+10.1%
Q4 2017$63,166,000
-15.1%
4,155,6700.0%2.72%
-13.2%
Q3 2017$74,386,000
+8.6%
4,155,670
-1.1%
3.13%
-2.0%
Q2 2017$68,513,000
+16.4%
4,203,2700.0%3.20%
+15.0%
Q1 2017$58,846,000
-12.2%
4,203,2700.0%2.78%
-27.3%
Q4 2016$67,042,000
-2.0%
4,203,270
+2.3%
3.82%
-3.7%
Q3 2016$68,402,000
+44.7%
4,110,708
-2.7%
3.97%
+11.2%
Q2 2016$47,285,000
+40.3%
4,225,608
+4.8%
3.57%
+36.5%
Q1 2016$33,698,000
-10.2%
4,030,9080.0%2.62%
+25.2%
Q4 2015$37,528,000
-16.8%
4,030,908
+0.8%
2.09%
-3.6%
Q3 2015$45,087,000
-8.8%
3,997,108
+2.6%
2.17%
-1.4%
Q2 2015$49,458,000
+39.8%
3,897,408
+2.5%
2.20%
+25.7%
Q1 2015$35,372,000
-34.8%
3,803,408
+0.4%
1.75%
-45.1%
Q4 2014$54,229,000
+59.1%
3,786,908
+15.3%
3.18%
+25.0%
Q3 2014$34,079,000
-35.0%
3,283,124
+1.3%
2.55%
-34.8%
Q2 2014$52,430,000
-49.8%
3,240,424
-49.6%
3.90%
-9.6%
Q1 2014$104,502,000
+160.0%
6,430,848
+98.6%
4.32%
+15.2%
Q4 2013$40,191,000
+26.2%
3,238,624
+11.4%
3.75%
+12.3%
Q3 2013$31,846,000
+65.5%
2,908,314
+22.1%
3.34%
+47.0%
Q2 2013$19,246,0002,381,8762.27%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders